Company intelligence / Profile preview

eQcell

Guelph, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

eQcell has completed enrollment in two novel equine clinical trials in Canada and the USA, is currently enrolling in one equine and one canine trial in Canada, and is preparing for a pivotal trial anticipated for 2026 to pursue marketing approval for its cell therapies

Therapeutic areas: Other
Modalities: Stem cell therapyCell therapyMesenchymal stromal cell (MSC) therapy
Industry: Veterinary

Partnerships

University of Guelph (Ontario Veterinary College)

Beyond the preview

Go deeper on eQcell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eQcell.

Explore the full profile